发明授权
![Substituted imidazo[1,2-a]pyridine derivatives](/docs/US/2005-07-12/US06916826B2/abs.jpg.600x600.jpg)
- 专利标题： Substituted imidazo[1,2-a]pyridine derivatives
- 专利标题（中）： 取代的咪唑并[1,2-a]吡啶衍生物
-
申请号： US10809068申请日： 2004-03-25
-
公开(公告)号： US06916826B2公开(公告)日： 2005-07-12
- 发明人: Vincent Mutel , Jens-Uwe Peters , Juergen Wichmann
- 申请人： Vincent Mutel , Jens-Uwe Peters , Juergen Wichmann
- 申请人地址： US NJ Nutley
- 专利权人： Hoffman-La Roche Inc.
- 当前专利权人： Hoffman-La Roche Inc.
- 当前专利权人地址： US NJ Nutley
- 代理商 George W. Johnston; Patricia S. Rocha-Tramaloni; Kimberly J. Prior
- 优先权： EP01107562 20010327
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/437 ; A61P9/10 ; A61P21/04 ; A61P25/00 ; A61P25/08 ; A61P25/14 ; A61P25/16 ; A61P25/18 ; A61P25/22 ; A61P25/24 ; A61P25/28 ; A61P43/00
![Substituted imidazo[1,2-a]pyridine derivatives](/abs-image/US/2005/07/12/US06916826B2/abs.jpg.150x150.jpg)
摘要：
The present invention is a series of novel compounds of formula I and a method of treatment or prevention of a mGluR5 receptor mediated disease by administering an therapeutically effective amount of a compound formula wherein R1 and R2 are selected from hydrogen, (C1-6)-alkyl, halogen, hydroxy, (C1-6)-alkoxy and A is defined the description, or a pharmaceutically acceptable salt thereof.
公开/授权文献
- US20040180921A1 Substituted imidazo[1,2-a]pyridine derivatives 公开/授权日：2004-09-16
信息查询
